Description
FenoldopamisabenzazepinederivativethatactsasapartialagoNISTatD1receptors;itmayalsoinhibitα1-adrenergicreceptors.Fenoldopamexhibitsvasodilatory,antihypertensive,andnatriureticactivities.Invivo,fenoldopamdecreasesbloodpressure,afterload,andbloodflow;italsoinhibitsNaClreabsorptioninthethickascendinglimb,promotingNa+excretion.
References
GriderJS,OttCE,JacksonBA.DopamineD1receptor-dependentinhibitionofNaCltransportintheratthickascendinglimb:mechanismofaction.EurJPharmacol.2003Jul25;473(2-3):185-90.PMID:12892837.
SchaferJA,LiL,SunD.Thecollectingduct,dopamineandvasopressin-dependenthypertension.ActaPhysiolScand.2000Jan;168(1):239-44.PMID:10691807.
MartinSW,BroadleyKJ.Renalvasodilatationbydopexamineandfenoldopamduetoalpha1-adrenoceptorblockade.BrJPharmacol.1995May;115(2):349-55.PMID:7670737.
GrenaderA,HealyDP.Fenoldopamisapartialagonistatdopamine-1(DA1)receptorsinLLC-PK1cells.JPharmacolExpTher.1991Jul1;258(1):193-8.PMID:1677038.
NicholsAJ,RuffoloRRJr,BrooksDP.Thepharmacologyoffenoldopam.AmJHypertens.1990Jun;3(6Pt2):116S-119S.PMID:1974439.